Protech Biopharma Private Limited

Protech Biopharma Private Limited - pharma in Srinagar, Jammu And Kashmir, India. FY 2026 financials & compliance.
CIN U24233JK2007PTC002841 Incorporated 15 November 2007 ROC Jammu HQ Srinagar, Jammu And Kashmir, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹2.96 Cr
▼ 39% YoY
Net loss · FY 2025
₹1.08 Cr
Net margin -36.4%
EBITDA · FY 2025
-₹37.27 Lakh
EBITDA margin -12.6%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Open charges
₹2 Cr
Secured borrowings
Company age
19 yrs
Est. 2007
Directors on board
2
As per MCA filings

About Protech Biopharma Private Limited

Data last updated:

Protech Biopharma Private Limited is a private limited company based in Srinagar, Jammu And Kashmir, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 November 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U24233JK2007PTC002841. Its GSTIN is 01AAECP5023B1ZA (Jammu and Kashmir). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Abdul Rehman Mir and Nazia Dar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dilkash Guest House First Floor Al Safa Market Sarai Bala, Srinagar, Jammu and Kashmir, India – 190001.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.96 Cr, a decline of 39% compared to the previous year. For the same year it recorded a net loss of ₹1.08 Cr (net margin -36.4%) and EBITDA of -₹37.27 Lakh (EBITDA margin -12.6%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 20% over five years.

The company is associated with 1 brand: Protech Biopharma. As per MCA filings, the company has open charges of ₹2 Cr on record. Court records list 1 case involving the company, including 1 filed against it.

Protech Biopharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-JK-15-0000226). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website protechbiopharma.com.

Company details

CIN U24233JK2007PTC002841
Registration Number 002841
Incorporation Date 15 November 2007
ROC Jammu
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-JK-15-0000226

Recognitions & Rankings of Protech Biopharma

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-JK-15-0000226

Contact details

Protech Biopharma Private Limited's registered office is in Srinagar, Jammu And Kashmir. Its website is protechbiopharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Dilkash Guest House First Floor Al Safa Market Sarai Bala, Srinagar, Jammu and Kashmir, India – 190001
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Protech Biopharma Private Limited, buy the company report.

Comprehensive company report
Protech Biopharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Protech Biopharma operates one associated brand: Protech Biopharma. Each brand links to its own profile.

BrandDescriptionWebsite
Produces high-quality biopharmaceutical products and offers CRAMS services.protechbiopharma.com

Business activity

The main business activity of Protech Biopharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Protech Biopharma Private Limited, buy the company report.

Financials of Protech Biopharma Private Limited

FY 2025 filings available

Protech Biopharma Private Limited reported revenue of ₹2.96 Cr (down 39% YoY) for FY 2025.

Revenue · FY 2025
₹2.96 Cr ▼ 39%
Net loss · FY 2025
₹1.08 Cr margin -36.4%
EBITDA · FY 2025
-₹37.27 Lakh margin -12.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 39%
3 years · compounded
▼ 2%
5 years · compounded
▼ 20%
EBITDA CAGR growth
1 year
▼ 139%
3 years · compounded
▼ 35%
5 years · compounded
▼ 17%

Revenue has declined at a compounded annual rate (CAGR) of 20% over five years, including a 39% fall in the latest year. EBITDA fell 139% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹37.27 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.08 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-12.6%
Net Profit Margin-36.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Protech Biopharma Private Limited, buy the company report.

Board of directors of Protech Biopharma Private Limited

Protech Biopharma has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Abdul Rehman MirDirector14 Dec 20214 Years 11 MonthsCurrent
Nazia DarDirector14 Dec 20241 Years 11 MonthsCurrent

Peer comparison

Protech Biopharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Biopharma, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Protech Biopharma Private Limitedthis company₹2.96 Cr (FY 2025)-₹1.08 Cr-36.4%-39.0%Srinagar, Jammu And Kashmir, India
GMH Pharmaceuticals Pvt Ltd₹2.94 Cr (FY 2025)-7.0%Chandigarh, India
Zeal Organosys Private Limited₹2.94 Cr (FY 2025)20.0%Delhi, India
Zanjoe Formulations Private Limited₹2.93 Cr (FY 2025)124.0%Patna, Bihar, India

To see the full peer comparison of Protech Biopharma Private Limited, buy the company report.

Auditor

Protech Biopharma Private Limited is audited by INYT & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
INYT & COFY 2023030141N

Shareholding

The shareholding of Protech Biopharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Protech Biopharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹2 Cr
Satisfied charges
None
Breakdown by lending institutions
Jammu and Kashmir Bank₹1.51 Cr
The Jammu and Kashmir Bank Limited₹0.43 Cr
Hdfc Bank Limited₹0.06 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Jun 2025101175059The Jammu and Kashmir Bank Limited₹2.86 LakhOpen
09 Sep 2022100628646The Jammu and Kashmir Bank Limited₹2.6 LakhOpen
14 Dec 2021100520367The Jammu and Kashmir Bank Limited₹26 LakhOpen
23 Nov 2021100529172Hdfc Bank Limited₹5.68 LakhOpen
28 Nov 2017100155729The Jammu and Kashmir Bank Limited₹3 LakhOpen

Total charge records: 8 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Protech Biopharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Protech Biopharma has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
01AAECP5023B1ZAJammu and KashmirActive08 Jul 2017

To see the full GST registrations and return filing status of Protech Biopharma Private Limited, buy the company report.

Recent activity

Protech Biopharma Private Limited has 8 board changes on record since 2010: 2 appointments and 6 cessations. The latest: Nazia Dar was appointed as Director on 14 Dec 2024.

AGM
Protech Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with The Jammu And Kashmir Bank Limited amounted to Rs. 2.86 Lakh with Charge ID 101175059 was registered on 30 Jun 2025.
Filing
Protech Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jammu.
Appointed
Nazia Dar was appointed as Director.
Charges
A charge with The Jammu And Kashmir Bank Limited amounted to Rs. 2.60 Lakh with Charge ID 100628646 was registered on 09 Sep 2022.
Ceased
Shailja Nandan Mishra ceased to be Director.
Charges
A charge with The Jammu And Kashmir Bank Limited amounted to Rs. 26.00 Lakh with Charge ID 100520367 was registered on 14 Dec 2021.
Appointed
Abdul Rehman Mir was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 5.68 Lakh with Charge ID 100529172 was registered on 23 Nov 2021.
Ceased
Dharmendra Mani Tripathi ceased to be Additional Director.
Ceased
Waheed Ul Rehman ceased to be Director.
Ceased
Deepak Koul ceased to be Managing Director.

7 earlier events are in the company report.

Frequently asked questions

Protech Biopharma is an active private limited company based in Srinagar, Jammu And Kashmir, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 November 2007 (19+ years old) and is registered under CIN U24233JK2007PTC002841.

Protech Biopharma has 2 current directors:

The latest financial statements of Protech Biopharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Protech Biopharma is 01AAECP5023B1ZA, registered in Jammu and Kashmir. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Protech Biopharma is U24233JK2007PTC002841. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Protech Biopharma has 1 court case on record: 1 filed against it.

Protech Biopharma was incorporated on 15 November 2007, making it 19+ years old. It is registered with the Registrar of Companies, Jammu.

The peers of Protech Biopharma by revenue are GMH Pharmaceuticals Pvt Ltd, Zeal Organosys Private Limited, Zanjoe Formulations Private Limited, all in the Pharma industry (Biopharma, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Nazia Dar was appointed as Director on 14 Dec 2024. Shailja Nandan Mishra ceased to be Director on 15 Dec 2021. Abdul Rehman Mir was appointed as Director on 14 Dec 2021. Protech Biopharma has 8 board changes on record in total.

Yes, Protech Biopharma is registered as a small enterprise under Udyam registration (number: UDYAM-JK-15-0000226).

Protech Biopharma can be reached through the website protechbiopharma.com. Its registered office is in Srinagar, Jammu And Kashmir, India.